NASAL
FROM DEVICE SELECTION TO REGULATORY APPROVAL: ACCELERATING THE NEXT GENERATION OF INTRANASAL THERAPIES
Joseph DePalo discusses the increasingly diverse range of therapeutics that have the potential to be delivered nasally, delving into the offerings developed by Bespak in collaboration with other contract organisations that expand the possibilities of nasal drug delivery, as well as providing an integrated approach across device development.